Publication Annual Report – Annual Shareholders' Meeting
April 15 2024 - 10:16AM
Publication Annual Report – Annual
Shareholders' Meeting
Leuven, BELGIUM – April 15, 2024 – 05:00 PM CET
Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company
headquartered in Leuven, has today published its annual report for
the financial year 2023. The annual report for the year ending
December 31, 2023 is available in the “Investors” section of the
Company’s website, and can also be downloaded as a PDF.
On this day as well, the Company has convened its Annual
Shareholders' Meeting. The relevant documents pertaining to this
Meeting have been published in the section “Shareholder Meetings”
here.
About Oxurion
Oxurion (Euronext Brussels: OXUR) is engaged in
developing next-generation standard of care ophthalmic therapies
for the treatment of retinal disease. Oxurion is based in Leuven,
Belgium. More information is available at www.oxurion.com.
Please contact for additional information:
Oxurion NVPascal GhosonChief Executive
Officerpascal.ghoson@oxurion.com |
Backstage CommunicationJurgen
VluijmansPartnerjurgen@backstagecom.be |
Oxurion NV (EU:OXUR)
Historical Stock Chart
From Nov 2024 to Dec 2024
Oxurion NV (EU:OXUR)
Historical Stock Chart
From Dec 2023 to Dec 2024